Concepedia

Xiaoli Ma

XM

Statistics

Publications

15

Citations

1.1K

H-Index

14

Active since

1991

Affiliations

Gilead Sciences (United States)(Current)

Toronto Liver Centre

Chinese University of Hong Kong

Kaohsiung Medical University

Kaohsiung Medical University Chung-Ho Memorial Hospital

Xiaoli Ma is an author at Gilead Sciences (United States) specializing in viral hepatitis, pharmacy, and viral hepatitis treatment.

Publications per year

1991–2023

15

Publications

15

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma et al. · Gastroenterology · 2015 · 338 citations · Full text

, , +17

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Carolina Boni, Harry L.A. Janssen, Marzia Rossi et al. · Gastroenterology · 2019 · 140 citations · Full text

, , +13

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

Pietro Lampertico, Scott Fung, Sang Hoon Ahn et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 139 citations

, , +16

Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis

Semyon I. Aleynik, Maria A. Leo, Xiaoli Ma et al. · Journal of Hepatology · 1997 · 129 citations

, , +15

Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B

Henry Lik‐Yuen Chan, Magdy Elkhashab, Huy N. Trinh et al. · Journal of Hepatology · 2015 · 62 citations

, , +14

1–5 of 15